OSEManagement•globenewswire•
OSE Immunotherapeutics Appoints Thomas Gidoin as Chief Financial Officer
Sentiment:Negative (20)
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 20, 2025 by globenewswire